This AI spots dangerous blood cells doctors often miss

Science News from research organizations This AI spots dangerous blood cells doctors often miss Date: January 13, 2026 Source: University of Cambridge Summary: A generative AI system can now analyze blood cells with greater accuracy and confidence than human experts, detecting subtle signs of...

Science News from research organizations This AI spots dangerous blood cells doctors often miss Date: January 13, 2026 Source: University of Cambridge Summary: A generative AI system can now analyze blood cells with greater accuracy and confidence than human experts, detecting subtle signs of diseases like leukemia. It not only spots rare abnormalities but also recognizes its own uncertainty, making it a powerful support tool for clinicians. Share: Facebook Twitter Pinterest LinkedIN Email FULL STORY A new AI system is showing it may be better than human experts at spotting dangerous changes in blood cells, potentially transforming how diseases like leukemia are diagnosed. Credit: Shutterstock A new artificial intelligence system that examines the shape and structure of blood cells could significantly improve how diseases such as leukemia are diagnosed. Researchers say the tool can identify abnormal cells with greater accuracy and consistency than human specialists, potentially reducing missed or uncertain diagnoses. The system, known as CytoDiffusion, relies on generative AI, the same type of technology used in image generators such as DALL-E, to analyze blood cell appearance in detail. Rather than focusing only on obvious patterns, it studies subtle variations in how cells look under a microscope. Moving Beyond Pattern Recognition Many existing medical AI tools are trained to sort images into predefined categories. In contrast, the team behind CytoDiffusion demonstrated that their approach can recognize the full range of normal blood cell appearances and reliably flag rare or unusual cells that may signal disease. The work was led by researchers from the University of Cambridge, University College London, and Queen Mary University of London, and the findings were published in Nature Machine Intelligence. Identifying small differences in blood cell size, shape, and structure is central to diagnosing many blood disorders. However, learning to do this well can take years of experience, and even highly trained doctors may disagree when reviewing complex cases. "We've all got many different types of blood cells that have different properties and different roles within our body," said Simon Deltadahl from Cambridge's Department of Applied Mathematics and Theoretical Physics, the study's first author. "White blood cells specialize in fighting infection, for example. But knowing what an unusual or diseased blood cell looks like under a microscope is an important part of diagnosing many diseases." Handling the Scale of Blood Analysis A standard blood smear can contain thousands of individual cells, far more than a person can realistically examine one by one. "Humans can't look at all the cells in a smear -- it's just not possible," Deltadahl said. "Our model can automate that process, triage the routine cases, and highlight anything unusual for human review." This challenge is familiar to clinicians. "The clinical challenge I faced as a junior hematology doctor was that after a day of work, I would face a lot of blood films to analyze," said co-senior author Dr. Suthesh Sivapalaratnam from Queen Mary University of London. "As I was analyzing them in the late hours, I became convinced AI would do a better job than me." Training on an Unprecedented Dataset To build CytoDiffusion, the researchers trained it on more than half a million blood smear images collected at Addenbrooke's Hospital in Cambridge. The dataset, described as the largest of its kind, includes common blood cell types, rare examples, and features that often confuse automated systems. Instead of simply learning how to separate cells into fixed categories, the AI models the entire range of how blood cells can appear. This makes it more resilient to differences between hospitals, microscopes, and staining techniques, while also improving its ability to detect rare or abnormal cells. Detecting Leukemia With Greater Confidence When tested, CytoDiffusion identified abnormal cells associated with leukemia with much higher sensitivity than existing systems. It also performed as well as or better than current leading models, even when trained with far fewer examples, and was able to quantify how confident it was in its own predictions. "When we tested its accuracy, the system was slightly better than humans," said Deltadahl. "But where it really stood out was in knowing when it was uncertain. Our model would never say it was certain and then be wrong, but that is something that humans sometimes do." Co-senior author Professor Michael Roberts from Cambridge's Department of Applied Mathematics and Theoretical Physics said the system was evaluated against real-world challenges faced by medical AI. "We evaluated our method against many of the challenges seen in real-world AI, such as never-before-seen images, images captured by different machines and the degree of uncertainty in the labels," he said. "This framework gives a multi-faceted view of model performance which we believe will be beneficial to researchers." When AI Images Fool Human Experts The team also found that CytoDiffusion can generate synthetic images of blood cells that look indistinguishable from real ones. In a 'Turing test' involving ten experienced hematologists, the specialists were no better than random chance at telling real images apart from those created by the AI. "That really surprised me," Deltadahl said. "These are people who stare at blood cells all day, and even they couldn't tell." Opening Data to the Global Research Community As part of the project, the researchers are releasing what they describe as the world's largest publicly available collection of peripheral blood smear images, totaling more than half a million samples. "By making this resource open, we hope to empower researchers worldwide to build and test new AI models, democratize access to high-quality medical data, and ultimately contribute to better patient care," Deltadahl said. Supporting, Not Replacing, Clinicians Despite the strong results, the researchers emphasize that CytoDiffusion is not intended to replace trained doctors. Instead, it is designed to assist clinicians by quickly flagging concerning cases and automatically processing routine samples. "The true value of healthcare AI lies not in approximating human expertise at lower cost, but in enabling greater diagnostic, prognostic, and prescriptive power than either experts or simple statistical models can achieve," said co-senior author Professor Parashkev Nachev from UCL. "Our work suggests that generative AI will be central to this mission, transforming not only the fidelity of clinical support systems but their insight into the limits of their own knowledge. This 'metacognitive' awareness -- knowing what one does not know -- is critical to clinical decision-making, and here we show machines may be better at it than we are." The team notes that additional research is needed to increase the system's speed and to validate its performance across more diverse patient populations to ensure accuracy and fairness. The research received support from the Trinity Challenge, Wellcome, the British Heart Foundation, Cambridge University Hospitals NHS Trust, Barts Health NHS Trust, the NIHR Cambridge Biomedical Research Centre, NIHR UCLH Biomedical Research Centre, and NHS Blood and Transplant. The work was carried out by the Imaging working group within the BloodCounts! consortium, which aims to improve blood diagnostics worldwide using AI. Simon Deltadahl is a Member of Lucy Cavendish College, Cambridge. RELATED TOPICS Health & Medicine Today's Healthcare Heart Disease Diseases and Conditions Medical Devices Computers & Math Statistics Artificial Intelligence Computer Modeling Computers and Internet RELATED TERMS Cancer Adult stem cell Embryonic stem cell Stem cell Bone marrow Blood transfusion Immune system Electrocardiogram Story Source: Materials provided by University of Cambridge. Note: Content may be edited for style and length. Journal Reference: Simon Deltadahl, Julian Gilbey, Christine Van Laer, Nancy Boeckx, Mathie P. G. Leers, Tanya Freeman, Laura Aiken, Timothy Farren, Matthew Smith, Mohamad Zeina, Stephen MacDonald, Daniel Gleghorn, Martijn Schut, Folkert Asselbergs, Sujoy Kar, Sophie Williams, Mickey Koh, Yvonne Henskens, Norbert de Wit, Umberto D’Alessandro, Bubacarr Bah, Ousman Secka, Rajeev Gupta, Sara Trompeter, Christine van Laer, Gordon A. Awandare, Kwabena Sarpong, Lucas Amenga-Etego, Willem H. Ouwehand, James H. F. Rudd, James HF Rudd, Concetta Piazzese, Joseph Taylor, Nicholas Gleadall, Carola-Bibiane Schönlieb, Suthesh Sivapalaratnam, Michael Roberts, Parashkev Nachev. Deep generative classification of blood cell morphology. Nature Machine Intelligence, 2025; 7 (11): 1791 DOI: 10.1038/s42256-025-01122-7 Cite This Page: MLA APA Chicago University of Cambridge. "This AI spots dangerous blood cells doctors often miss." ScienceDaily. ScienceDaily, 13 January 2026. . University of Cambridge. (2026, January 13). This AI spots dangerous blood cells doctors often miss. ScienceDaily. Retrieved July 13, 2026 from www.sciencedaily.com/releases/2026/01/260112214317.htm University of Cambridge. "This AI spots dangerous blood cells doctors often miss." ScienceDaily. www.sciencedaily.com/releases/2026/01/260112214317.htm (accessed July 13, 2026). Explore More from ScienceDaily RELATED STORIES New AI Tool Visualizes a Cell's 'Social Network' to Help Treat Cancer Mar. 18, 2025 — An openly available generative AI tool can interpret millions of cells in human tissues in hours, revealing new insights and allowing researchers and clinicians to ask questions about conditions such ... Generative AI to Protect Image Privacy May 29, 2024 — Image privacy could be protected with the use of generative artificial intelligence. Researchers created a system which replaces parts of images that might threaten confidentiality with visually ... Battle of the AIs in Medical Research: ChatGPT Vs Elicit Dec. 9, 2023 — A research team has focused on generative AI as an information-gathering tool in the medical field. The results showed that one of the generative AIs suggested mostly fictitious references, while the ... World's Largest Association of Computing Professionals Issues Principles for Generative AI Technologies July 11, 2023 — In response to major advances in Generative AI technologies -- as well as the significant questions these technologies pose in areas including intellectual property, the future of work, and even ... Machine Learning Outperforms Clinical Experts in Classifying Hip Fractures Feb. 11, 2022 — A new machine learning process designed to identify and classify hip fractures has been shown to outperform human clinicians. Two convolutional neural networks (CNNs) were able to identify and ... How the Brain Accounts for Uncertainties in Motor Planning Sep. 14, 2021 — Major league baseball players must decide whether and how to swing at a pitch based only on the first 10 to 20 percent of the ball's flight when there is still a lot of uncertainty about the ... TRENDING AT SCITECHDAILY.com Astronomers Find a New Clue for Detecting Runaway Supermassive Black Holes Why You Hate Eating Bugs: DNA Reveals a 9,000-Year-Old Legacy Coffee May Protect the Liver in More Ways Than Scientists Realized The Hidden Health Risk of Sitting for Hours Without a Break

Source: ScienceDaily AI — Published January 13, 2026 at 13:50 UTC — Category: Research